W Kester - Blackrock Innovation Independent Trustee
| BIGZ Stock | USD 7.99 0.07 0.88% |
Insider
W Kester is Independent Trustee of Blackrock Innovation Growth since 2021.
| Age | 70 |
| Tenure | 3 years |
| Address | 50 Hudson Yards, New York, NY, United States, 10001 |
| Phone | 212 810 5300 |
W Kester Latest Insider Activity
Tracking and analyzing the buying and selling activities of W Kester against Blackrock Innovation stock is an integral part of due diligence when investing in Blackrock Innovation. W Kester insider activity provides valuable insight into whether Blackrock Innovation is net buyers or sellers over its current business cycle. Note, Blackrock Innovation insiders must abide by specific rules, including filing SEC forms every time they buy or sell Blackrock Innovation'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
W Kester over a month ago Acquisition by W Kester of 209 shares of BlackRock Credit subject to Rule 16b-3 | ||
W Kester over two months ago Acquisition by W Kester of 170 shares of BlackRock Limited subject to Rule 16b-3 | ||
W Kester over six months ago Acquisition by W Kester of 294 shares of BlackRock Limited subject to Rule 16b-3 | ||
W Kester over six months ago Acquisition by W Kester of 169 shares of BlackRock Limited subject to Rule 16b-3 |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Debra Rubano | Allianzgi Diversified Income | 45 | |
| J Holloman | Blackrock Resources Commodities | 66 | |
| Erick Holt | Allianzgi Diversified Income | 67 | |
| Philip Mcloughlin | Allianzgi Diversified Income | 74 | |
| Xiang Liu | BlackRock Health Sciences | N/A | |
| Peter Trapp | Neuberger Berman Next | 27 | |
| Cynthia Egan | BlackRock Science Tech | 66 | |
| Savonne Ferguson | Neuberger Berman Next | 48 | |
| Tom Seip | Neuberger Berman Next | 71 | |
| Martha Goss | Neuberger Berman Next | 72 | |
| George Aylward | Allianzgi Diversified Income | 56 | |
| Jonathan Diorio | BlackRock Health Sciences | 41 | |
| Julia Short | Allianzgi Diversified Income | 48 | |
| Sheila James | Neuberger Berman Next | 56 | |
| Marc Gary | Neuberger Berman Next | 69 | |
| R Hubbard | BlackRock Science Tech | 61 | |
| J Holloman | BlackRock Science Tech | 66 | |
| Stayce Harris | Blackrock Resources Commodities | 62 | |
| Catherine Lynch | BlackRock Health Sciences | 60 | |
| Stayce Harris | BlackRock Health Sciences | 62 | |
| Candace Straight | Neuberger Berman Next | 74 | |
Blackrock Innovation Leadership Team
Elected by the shareholders, the Blackrock Innovation's board of directors comprises two types of representatives: Blackrock Innovation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Blackrock. The board's role is to monitor Blackrock Innovation's management team and ensure that shareholders' interests are well served. Blackrock Innovation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Blackrock Innovation's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen Robards, Independent Co-Chairman of the Board and Trustee | ||
| Richard Cavanagh, Independent Co-Chairman Board and Trustee | ||
| Charles Park, Chief Compliance Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| Jonathan Diorio, Vice President | ||
| R Hubbard, Independent Trustee | ||
| Robert Fairbairn, Trustee | ||
| Trent Walker, Chief Financial Officer | ||
| W Kester, Independent Trustee |
Blackrock Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Blackrock Innovation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 213.34 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 27.43 % | |||
| Number Of Shares Shorted | 174.04 K | |||
| Price To Book | 0.89 X | |||
| Price To Sales | 7.72 X | |||
| Total Debt | 40.69 M | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | 0.89 X | |||
| Market Capitalization | 1.69 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Blackrock Stock Analysis
When running Blackrock Innovation's price analysis, check to measure Blackrock Innovation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blackrock Innovation is operating at the current time. Most of Blackrock Innovation's value examination focuses on studying past and present price action to predict the probability of Blackrock Innovation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blackrock Innovation's price. Additionally, you may evaluate how the addition of Blackrock Innovation to your portfolios can decrease your overall portfolio volatility.